Abstract:Background 11 has been reported that CD8(+) regulatory cells could be induced upon oral tolerance. The purpose of this study was to investigate the changes of CD8 alpha(+) T cells in dextran sulfate sodium (DSS)-induced colitis mice pretreated by oral immune regulation.Methods The effects of five low oral doses of colitis-extracted proteins (CEP) on colitis were evaluated by clinical manifestation and histological lesions. The percentages of CD8 alpha(+) T cells gating on CD3(+) T cells were evaluated in the gut-associated lymphoid tissues (GALT) and the spleens by flow cytometry. Differences between the two groups were compared by Student's t test or Mann-Whitney U test.Results Compared to bovine serum albumin (BSA)-fed control mice, administration of CEP resulted in marked alleviation of colitis. The proportion of CD8 alpha(+) T cells, not only in intraepithelial lymphocytes (IELs) and lamina propria lymphocytes (LPLs) of the large intestine (LI) but also in spleen from CEP-fed colitis mice, was significantly higher than that from BSA-fed colitis mice (LI-IELs: (71.5 +/- 5.4)% vs. (60.1 +/- 4.3)%, P<0.01; LI-LPLs: (60.7 +/- 5.2)% vs. (51.9 +/- 4.7)%, P <0.01; spleen: (24.1 +/- 3.6)% vs. (20.3 +/- 4.1)%, P <0.05; n=8). Mucosal repair in repair-period mice five days after termination of DSS treatment was also accompanied by an increase of CD8 alpha(+) T cells in large intestinal mucosal lymphocytes (LI-IELs: (72.1 3.7)% vs. (61.5 4.5)%, P<0.01; LI-LPLs: (62.1 +/- 5.7)% vs. (52.7 +/- 3.6)%, P<0.01; n=8). The proportion of CD3(+) T cells increased in Peyer's patches (PPs) and decreased in mesenteric lymph nodes (MLNs) from colitis mice compared to untreated mice, whereas the change pattern of CD3(+) T cells in PPs and MLNs from CEP-fed colitis mice was just on the contrary.Conclusion Improvement of DSS-induced colitis resulted from oral immune regulation is associated with an increase in CD8 alpha(+) T cells in spleen and large intestinal mucosa. Chin Med J 2012;125(12):2173-2179

Activated Syndecan-1 Shedding Contributes to Mice Colitis Induced by Dextran Sulfate Sodium

Changes of CD8⁺ T Cells in Dextran Sulfate Sodium-Induced Colitis Mice Pretreated with Oral Immune Regulation.

The effect of oral tolerance on the roles of small intestinal intraepithelial lymphocytes in murine colitis induced by dextran sodium sulfate

The Protective Effect Of Oral Colitis-Derived Proteins In A Murine Model Of Inflammatory Bowel Disease Is Associated With An Increase In Gamma Delta T Cells In Large Intestinal Mucosa

The protective effect of oral colitis-derived proteins in a murine model of inflammatory bowel disease is associated with an increase in γδ T cells in large intestinal mucosa

Inhibition of Myeloid Differentiation 1 Specifically in Colon with Antisense Oligonucleotide Exacerbates Dextran Sodium Sulfate-Induced Colitis

MD-1 Deficiency Attenuates Dextran Sodium Sulfate (Dss)-Induced Colitis Through Modulating the Function of Colonic Lamina Propria Dendritic Cells

Histological and Ultrastructural Changes of the Colon in Dextran Sodium Sulfate-Induced Mouse Colitis

SDH, a novel diarylheptane compound, alleviates dextran sulfate sodium (DSS)-induced colitis by reducing Th1/Th2/Th17 induction and regulating the gut microbiota in mice

High fat diet exacerbates dextran sulfate sodium induced colitis through disturbing mucosal dendritic cell homeostasis.

Deoxycholic acid exacerbates intestinal inflammation by modulating interleukin-1 β expression and tuft cell proportion in dextran sulfate sodium-induced murine colitis.

Expression of heparan sulfate proteoglycans in murine models of experimental colitis

Inhibition of Phosphoinositide 3-Kinase Ameliorates Dextran Sodium Sulfate-Induced Colitis in Mice

Decitabine Attenuates Dextran Sodium Sulfate‑induced Ulcerative Colitis Through Regulation of Immune Regulatory Cells and Intestinal Barrier.

Interleukin-36β Exacerbates DSS-induce Acute Colitis Via Inhibiting Foxp3+ Regulatory T Cell Response and Increasing Th2 Cell Response.

Characterisation of Acute Murine Dextran Sodium Sulphate Colitis: Cytokine Profile and Dose Dependency

The Role of CD19+CD5+CD1dhi B Cells in Dextran Sulfact Sodium (dss)induced Inflammatory Bowel Disease C57BL/6 Mouse Model

Trans-10-Hydroxy-2-Decenoic Acid Alleviates Dextran Sulfate Sodium-Induced Colitis in Mice Via Regulating the Inflammasome-Mediated Pyroptotic Pathway and Enhancing Colonic Barrier Function

Didymin Ameliorates Dextran Sulfate Sodium (DSS)-Induced Ulcerative Colitis by Regulating Gut Microbiota and Amino Acid Metabolism in Mice

[WDSUB1 knockdown alleviates dextran sulfate sodium-induced colitis in mice by inhibiting nuclear factor-κB signaling pathway]

Effect of chitosan on dextran sulfate sodium sulfate-induced ulcerative colitis in mice